News
Corticosteroid Exposure Affects Bone Health in Asthma Patients
Oral, inhaled corticosteroid use linked to increased risk for osteoporosis, fragility fractures
Your search for oral corticosteroids returned 35 results
News
Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
Highest rates of adverse events seen within first month after initiating short course of oral steroids.
News
Guideline Details Pharmacologic Management of COPD
Clinical practice guideline addresses 6 emerging questions around COPD management.
AAAAI 2020, News
High Doses of Inhaled Corticosteroids Reduce Eosinophil Levels in Asthma
High doses of inhaled corticosteroids were associated with lower levels of eosinophils, which may interfere with the recommendation of some monoclonal antibodies in asthma treatment.
ACR 2019, News
Guselkumab Demonstrates Efficacy in Biologic-Naive or TNFi-Treated Patients With Psoriatic Arthritis
Researchers evaluated the efficacy and safety of guselkumab in patients with active psoriatic arthritis who were biologic-naive or treated with prior tumor necrosis factor inhibitors.
News
Mycophenolate Mofetil Does Not Top MTX in Noninfectious Uveitis
Control of inflammation not superior with mycophenolate mofetil versus methotrexate
News
Tramadol as First-Line Therapy for OA May Be Associated With Greater Mortality
Treating osteoarthritis in older patients with tramadol vs nonsteroidal anti-inflammatory drugs may be associated with an increased mortality rate during the year following treatment initiation.
News
Guidelines Developed for Managing Severe Atopic Dermatitis
Management is generally in a stepwise manner, including moisturizers and avoiding triggers
News
Respiratory Pathogens May Up Treatment Failure Risk in Asthma
There was a correlation for non-rhinovirus pathogens with increased absolute risk of treatment failure by 13.1%; specifically, by 8.8, 24.9, and 34.1% for respiratory syncytial virus, influenza, and parainfluenza, respectively.
News
Sirolimus May Be Beneficial in DIPNECH Syndrome
The patients began treatment with oral sirolimus; after 1 year of treatment, there was improvement in exertional dyspnea in all 3 patients.
